Dr. Albiruni Abdul Razak

Dr. Abdul Razak is an assistant professor at the University of Toronto. Clinically, he is a staff medical oncologist in phase 1 clinical trials and sarcoma at the Princess Margaret Cancer Centre and at Sinai Health, Toronto. He also leads the Medical Oncology Sarcoma Program at both institutions.

Originally from Malaysia, he underwent medical and oncology training in Ireland, England as well as Canada. He is the recipient of several international awards, including the Young Investigator Award from the American Society of Clinical Oncology (2011), Merit Award from the Conquer Cancer Foundation (2011) and the Mick Knighton Mesothelioma Award from the British Lung Foundation (2007). Nationally, Dr. Abdul Razak was also the inaugural recipient of the Sarcoma Cancer Foundation of Canada Fellowship (2013). Locally, his work was recognized by the McCullough and Till Paper of the Year Award (2017) and the Young Investigator Award for Division of Medical Oncology and Hematology, University of Toronto (2019).

Dr. Razak’s main interest is new drug development, especially in the field of sarcoma. He has authored papers for publications such as Journal of Clinical Oncology, Cancer Discovery, Clinical Cancer Research and Cancer. He was also the author of the oncology chapter for Davidson’s Textbook of Medicine (23rd and 24th edition). He has published over 100 peer-reviewed articles.

Dr. Razak has trained the next generation of sarcoma oncologists from various parts of the world including North America, Europe, Asia and Australia. These fellows have since launched their own successful collaborations. Dr. Razak also has been integral in connecting and training the next generation of drug developers from Ireland and Malaysia within his role at the Drug Development Program at PMCC.